Uploaded February 2026 | Updated September 2026, 2 weeks ago
PSA spikes, abnormal MRI results, and high PI-RADS scores often trigger immediate fear, and for many men, that fear leads straight to biopsy.
In this episode, Dr. Stephen Petteruti breaks down what PSA actually measures, how MRI technology fits into modern prostate cancer management, and why a high PI-RADS score does not automatically equal aggressive disease. Dr. Stephen discusses active surveillance, non-biopsy monitoring strategies, cardiovascular risk, hormone balance, and why overtreatment may compromise quality of life more than the cancer itself.
For men who value proactive healthcare, evidence-based medicine, testosterone preservation, and long-term vitality, this conversation offers clarity in a space dominated by urgency and assumption. It reframes prostate cancer care around informed consent, individualized risk assessment, and protection of both lifespan and healthspan.
Before agreeing to your next scan or biopsy, press pause. Listen carefully. Ask better questions. Watch the episode of Stop the Prostate Biopsy Frenzy: The Truth About MRI, PI-RADS, and PSA.
Key Points:
00:00 Introduction
01:09 Why Other Physicians Still Do It
01:42 MRI over biopsy
03:49 Biopsy spread risk concerns
04:06 Understanding Systemic Therapy
04:32 Intratest Variability
05:16 MRI Test Result Is Subjective
06:01 Gadolinium Contrast
07:19 Biparametric Vs. Multiparametric MRI
09:24 Radiation: Micro Ultrasounds
11:07 ROI For Doctors
12:45 Different Types Of Recommendations
13:29 Purpose Of MRI In Petteruti Protocol
14:34 Biparametric MRI Protocol
Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.
Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone, and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.
📚 Resources
Dr. Petteruti Men's Vitality Group
intellectualmedicine.com/membership
Fight Cancer Like a Man Book
amazon.com/Fight-Cancer-Like-Man-Breakthrough/dp/B0GP6JHQTQ
Dr. Petteruti's Newsletter
drstephenpetteruti.substack.com/subscribe
Podcast Show Notes
intellectualmedicine.com/podcast-notes
🌐 Learn More
Dr. Stephen Petteruti
drstephenpetteruti.com
Intellectual Medicine
intellectualmedicine.com
📱 Connect with Dr. Petteruti
Instagram
instagram.com/dr.stephenpetteruti
Facebook
facebook.com/dr.stephenpetteruti
🎧 Listen to the Podcast
Apple Podcasts
podcasts.apple.com/us/podcast/intellectual-medicine/id1458649409
Spotify
open.spotify.com/show/3om1BQGP8f0hODZ6neWCd1
#BiparametricMRI #ProstateImaging #ContrastFree
PSA spikes, abnormal MRI results, and high PI-RADS scores often trigger immediate fear, and for many men, that fear leads straight to biopsy.
In this episode, Dr. Stephen Petteruti breaks down what PSA actually measures, how MRI technology fits into modern prostate cancer management, and why a high PI-RADS score does not automatically equal aggressive disease. Dr. Stephen discusses active surveillance, non-biopsy monitoring strategies, cardiovascular risk, hormone balance, and why overtreatment may compromise quality of life more than the cancer itself.
For men who value proactive healthcare, evidence-based medicine, testosterone preservation, and long-term vitality, this conversation offers clarity in a space dominated by urgency and assumption. It reframes prostate cancer care around informed consent, individualized risk assessment, and protection of both lifespan and healthspan.
Before agreeing to your next scan or biopsy, press pause. Listen carefully. Ask better questions. Watch the episode of Stop the Prostate Biopsy Frenzy: The Truth About MRI, PI-RADS, and PSA.
Key Points:
00:00 Introduction
01:09 Why Other Physicians Still Do It
01:42 MRI over biopsy
03:49 Biopsy spread risk concerns
04:06 Understanding Systemic Therapy
04:32 Intratest Variability
05:16 MRI Test Result Is Subjective
06:01 Gadolinium Contrast
07:19 Biparametric Vs. Multiparametric MRI
09:24 Radiation: Micro Ultrasounds
11:07 ROI For Doctors
12:45 Different Types Of Recommendations
13:29 Purpose Of MRI In Petteruti Protocol
14:34 Biparametric MRI Protocol
Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.
Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone, and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.
📚 Resources
Dr. Petteruti Men's Vitality Group
intellectualmedicine.com/membership
Fight Cancer Like a Man Book
amazon.com/Fight-Cancer-Like-Man-Breakthrough/dp/B0GP6JHQTQ
Dr. Petteruti's Newsletter
drstephenpetteruti.substack.com/subscribe
Podcast Show Notes
intellectualmedicine.com/podcast-notes
🌐 Learn More
Dr. Stephen Petteruti
drstephenpetteruti.com
Intellectual Medicine
intellectualmedicine.com
📱 Connect with Dr. Petteruti
instagram.com/dr.stephenpetteruti
facebook.com/dr.stephenpetteruti
🎧 Listen to the Podcast
Apple Podcasts
podcasts.apple.com/us/podcast/intellectual-medicine/id1458649409
Spotify
open.spotify.com/show/3om1BQGP8f0hODZ6neWCd1
#BiparametricMRI #ProstateImaging #ContrastFree
